Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · IEX Real-Time Price · USD

2.490

+0.130 (5.51%)

At close: Apr 26, 2024, 4:00 PM

2.460

-0.030 (-1.20%)

After-hours: Apr 26, 2024, 5:48 PM EDT

Nautilus Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	19.4	114.52	185.62	36.61	0.6
Short-Term Investments	154.02	69.95	160.11	40.14	16.06
Cash & Cash Equivalents	173.42	184.47	345.73	76.74	16.66
Cash Growth	-5.99%	-46.64%	350.51%	360.66%	-
Other Current Assets	3.42	2.74	3.49	0.92	0.31
Total Current Assets	176.84	187.21	349.22	77.66	16.96
Property, Plant & Equipment	36.9	32.57	31.86	6.21	1.12
Long-Term Investments	90.65	129.17	16.37	0	0
Other Long-Term Assets	1.18	1.11	1	1.14	0.46
Total Long-Term Assets	128.73	162.84	49.23	7.35	1.58
Total Assets	305.57	350.05	398.45	85.01	18.54
Accounts Payable	1.64	1.27	1.72	0.47	0.29
Current Debt	3.54	1.99	0.97	1.48	0
Other Current Liabilities	3.95	3.53	3.12	1.07	0.2
Total Current Liabilities	9.12	6.79	5.81	3.02	0.49
Long-Term Debt	31.09	28.34	29.06	3.3	0
Total Long-Term Liabilities	31.09	28.34	29.06	3.3	0
Total Liabilities	40.21	35.13	34.87	6.31	0.49
Total Debt	34.63	30.33	30.03	4.78	0
Debt Growth	14.18%	0.99%	528.94%	-	-
Retained Earnings	-202.24	-138.56	-80.64	-30.33	-14.71
Comprehensive Income	-0.26	-1.85	-0.18	0	0.01
Shareholders' Equity	265.35	314.92	363.58	-29.72	-14.51
Net Cash / Debt	138.79	154.14	315.7	71.97	16.66
Net Cash / Debt Growth	-9.96%	-51.17%	338.67%	332.00%	-
Net Cash Per Share	1.11	1.24	3.74	2.47	2.75
Working Capital	167.72	180.42	343.41	74.64	16.47
Book Value Per Share	2.12	2.53	4.30	-1.02	-2.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).